Article info
PDFEditorial
Palivizumab for children with Down syndrome: is the time right for a universal recommendation?
- Correspondence to Dr Bosco Paes, Department of Pediatrics (Neonatal Division), McMaster University, Hamilton L8S 4K1, Canada; paes{at}mcmaster.ca
Citation
Palivizumab for children with Down syndrome: is the time right for a universal recommendation?
Publication history
- Received October 24, 2018
- Revised December 11, 2018
- Accepted December 12, 2018
- First published December 27, 2018.
Online issue publication
August 06, 2019
Article Versions
- Previous version (6 August 2019).
- Previous version (6 August 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.